Moreover, the deletion of circNF1 by siRNA not only increased CD8+ T cell-mediated cytotoxicity against tumor cells but also rendered ESCC cells more sensitive to PD-L1 checkpoint blockade therapy in tumor-bearing NSG mice models. The gene discussed is CD8A; the disease is neoplasm.